Simvastatin/Omega-3-Acid Ethyl Esters

辛伐他汀/ω-3酸乙酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSimvastatin/Omega-3-Acid Ethyl Esters
Drug Alias Namesimvastatin/doconexent ethyl ester/icosapent ethyl ester
ClassificationSmall molecules
Mechanisms of ActionTriglyceride modulatorsLipid modulatorsHMG-CoA reductase inhibitors
TargetsHMG-CoA reductaseTriglycerideLipid
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes SimvastatinOmega-3-acid ethyl esters (Trygg Pharma)
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBasf SeSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau SpaBasf
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A